Coherus BioSciences
CHRS
$9.26
Share price
4.28%
Change (1 day)
-32.06%
Change (1 year)
Categories
Market capitalization of Coherus BioSciences (CHRS)
Market cap: $0.71 Billion
As of July 2022 Coherus BioSciences has a market cap of $0.71 Billion. This makes Coherus BioSciences the world's 4673th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Coherus BioSciences from 2014 to 2022
| Year | Market cap | Change |
|---|---|---|
| 2022 | $0.71 B | -41.5% |
| 2021 | $1.22 B | -2.13% |
| 2020 | $1.25 B | -1.16% |
| 2019 | $1.26 B | 104.96% |
| 2018 | $0.61 B | 19.62% |
| 2017 | $0.51 B | -57.95% |
| 2016 | $1.22 B | 37.21% |
| 2015 | $0.89 B | 65% |
| 2014 | $0.54 B |
End of Day market cap according to different sources
On Jul 6th, 2022 the market cap of Coherus BioSciences was reported to be:
$0.68 Billion
$0.68 Billion
$0.68 Billion
$0.68 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $131.89 B | 18,296.87% | 🇺🇸 USA |
 Repligen
RGEN | $9.62 B | 1,242.65% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $0.01 B | -98.47% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | $6.16 B | 759.95% | 🇺🇸 USA |